(Q26827487)

PubMed

main subject

hepatocellular carcinoma

1 reference

Jorge Filmus

1

1 reference

Mariana Capurro

series ordinal

2

1 reference

language of work or name

1 reference

May 2013

1 reference

1 reference

280

1 reference

PubMed

issue

10

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

PubMed

page(s)

2471-6

1 reference

1 reference

Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Opposing activities of Dally-like glypican at high and low levels of Wingless morphogen activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Fine-tuning of cell signaling by glypicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

The loss of glypican-3 induces alterations in Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Dally regulates Dpp morphogen gradient formation by stabilizing Dpp on the cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Drosophila glypican Dally-like acts in FGF-receiving cells to modulate FGF signaling during tracheal morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Liverome: a curated database of liver cancer-related gene signatures with self-contained context information

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Wnt/β-catenin signaling and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Drugging Wnt signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

WNT/beta-catenin signaling in liver health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

The core protein of glypican Dally-like determines its biphasic activity in wingless morphogen signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Glypican 4 modulates FGF signalling and regulates dorsoventral forebrain patterning in Xenopus embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Multimodal approaches to the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

7 January 2021

Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

7 January 2021

The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

7 January 2021

Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

7 January 2021

Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

7 January 2021

Glypican-3 as a serum marker for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

7 January 2021

Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12126

7 January 2021

Identifiers

DOI

10.1111/FEBS.12126

1 reference

Consolidated OpenCitations Corpus – April 2017

release_jlpqf7vaibbwxcio7wylk4ircq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jlpqf7vaibbwxcio7wylk4ircq

24 November 2022

mapped directly with Wikidata item

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

23305321

1 reference

Consolidated OpenCitations Corpus – April 2017